Home Tags Linker-payload

Tag: linker-payload

Araris Biotech and Taiho Pharmaceutical to Jointly Develop Next-Generation ADCs

Swiss oncology-focused Araris Biotech, a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich, which is pioneering the development of next generation, proprietary antibody-drug conjugate (ADC)-linker technology, has entered a collaboration agreement with Japanese R&S driven specialty pharma Taiho Pharmaceutical Co.
Magazines heap detail

Site Specific Conjugation of Hydrophobic Payloads Without Genetic Engineering

Site-specific conjugation leads to more homogeneous conjugates and allows control of the site of drug attachment. This approach frequently relies on antibody engineering to...